Cell Therapy Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Therapy Type (Autologous, Allogeneic); Product (Equipment, Consumables, Software and Services); Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, Three-Dimensional Technology); Application (Oncology, Cardiology, Orthopedic, Wound Management, Other Applications); End User (Hospitals, Regenerative Medicine Centers, Research Institutes), and Geography
Report Code: TIPRE00009666 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Cell therapy (CT) is the process of transplanting human cells to replace or repair damaged tissue or cells. Various methods can be used to carry out cell therapy. For instance, hematopoietic stem cell transplantation, also known as bone marrow transplant, is the most widely used cell therapy. It is used to treat a variety of blood cancers and blood-related conditions.
MARKET DYNAMICS
Cell therapy market is expected to grow due to factors such as increasing the biotechnology industry, rising healthcare expenditure, growing incidences of chronic diseases, and others. The market is expected to have growth opportunities in the emerging region as they are developing their genetic sectors rapidly.
MARKET SCOPE
The "Global Cell Therapy Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell therapy market with detailed market segmentation by therapy type, product, technology, application, end user, and geography. The global cell therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cell therapy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global cell therapy market is segmented on the basis of therapy type, product, technology, application, end user. Based on the therapy type the market is classified as autologous, and allogeneic. Based on product the market is segmented as equipment, consumables, software and services. Based on technology the market is segmented as somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology, and three-dimensional technology. Based on application the market is classified as oncology, cardiology, orthopedic, wound management and others. And based on end user the market is divided into hospitals, regenerative medicine centers, and research institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cell therapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell therapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell therapy market in these regions.
The reports cover key developments in the cell therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from cell therapy market are anticipated to lucrative growth opportunities in the future with the rising demand for cell therapy market in the global market. Below mentioned is the list of few companies engaged in the cell therapy market.
The report also includes the profiles of key cell therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Kolon TissueGene, Inc.
- MEDIPOST
- JCR Pharmaceuticals Co. Ltd.
- Stemedica Cell Technologies, Inc.
- Osiris Therapeutics, Inc.
- NuVasive, Inc.
- Fibrocell Science, Inc.
- Vericel Corporation
- Cells for Cells
- Celgene Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Cell therapy (CT) is the process of transplanting human cells to replace or repair damaged tissue or cells. Various methods can be used to carry out cell therapy. For instance, hematopoietic stem cell transplantation, also known as bone marrow transplant, is the most widely used cell therapy. It is used to treat a variety of blood cancers and blood-related conditions.
MARKET DYNAMICS
Cell therapy market is expected to grow due to factors such as increasing the biotechnology industry, rising healthcare expenditure, growing incidences of chronic diseases, and others. The market is expected to have growth opportunities in the emerging region as they are developing their genetic sectors rapidly.
MARKET SCOPE
The "Global Cell Therapy Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell therapy market with detailed market segmentation by therapy type, product, technology, application, end user, and geography. The global cell therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cell therapy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global cell therapy market is segmented on the basis of therapy type, product, technology, application, end user. Based on the therapy type the market is classified as autologous, and allogeneic. Based on product the market is segmented as equipment, consumables, software and services. Based on technology the market is segmented as somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology, and three-dimensional technology. Based on application the market is classified as oncology, cardiology, orthopedic, wound management and others. And based on end user the market is divided into hospitals, regenerative medicine centers, and research institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cell therapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell therapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell therapy market in these regions.
The reports cover key developments in the cell therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from cell therapy market are anticipated to lucrative growth opportunities in the future with the rising demand for cell therapy market in the global market. Below mentioned is the list of few companies engaged in the cell therapy market.
The report also includes the profiles of key cell therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Kolon TissueGene, Inc.
- MEDIPOST
- JCR Pharmaceuticals Co. Ltd.
- Stemedica Cell Technologies, Inc.
- Osiris Therapeutics, Inc.
- NuVasive, Inc.
- Fibrocell Science, Inc.
- Vericel Corporation
- Cells for Cells
- Celgene Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell Therapy Market - By Therapy Type
1.3.2 Cell Therapy Market - By Product
1.3.3 Cell Therapy Market - By Technology
1.3.4 Cell Therapy Market - By Application
1.3.5 Cell Therapy Market - By End User
1.3.6 Cell Therapy Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CELL THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL THERAPY - GLOBAL MARKET OVERVIEW
6.2. CELL THERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. AUTOLOGOUS
7.3.1. Overview
7.3.2. Autologous Market Forecast and Analysis
7.4. ALLOGENEIC
7.4.1. Overview
7.4.2. Allogeneic Market Forecast and Analysis
8. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. EQUIPMENT
8.3.1. Overview
8.3.2. Equipment Market Forecast and Analysis
8.4. CONSUMABLES
8.4.1. Overview
8.4.2. Consumables Market Forecast and Analysis
8.5. SOFTWARE AND SERVICES
8.5.1. Overview
8.5.2. Software and Services Market Forecast and Analysis
9. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. SOMATIC CELL TECHNOLOGY
9.3.1. Overview
9.3.2. Somatic Cell Technology Market Forecast and Analysis
9.4. CELL IMMORTALIZATION TECHNOLOGY
9.4.1. Overview
9.4.2. Cell Immortalization Technology Market Forecast and Analysis
9.5. VIRAL VECTOR TECHNOLOGY
9.5.1. Overview
9.5.2. Viral Vector Technology Market Forecast and Analysis
9.6. GENOME EDITING TECHNOLOGY
9.6.1. Overview
9.6.2. Genome Editing Technology Market Forecast and Analysis
9.7. CELL PLASTICITY TECHNOLOGY
9.7.1. Overview
9.7.2. Cell Plasticity Technology Market Forecast and Analysis
9.8. THREE-DIMENSIONAL TECHNOLOGY
9.8.1. Overview
9.8.2. Three-Dimensional Technology Market Forecast and Analysis
10. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. ONCOLOGY
10.3.1. Overview
10.3.2. Oncology Market Forecast and Analysis
10.4. CARDIOLOGY
10.4.1. Overview
10.4.2. Cardiology Market Forecast and Analysis
10.5. ORTHOPEDIC
10.5.1. Overview
10.5.2. Orthopedic Market Forecast and Analysis
10.6. WOUND MANAGEMENT
10.6.1. Overview
10.6.2. Wound Management Market Forecast and Analysis
10.7. OTHER APPLICATIONS
10.7.1. Overview
10.7.2. Other Applications Market Forecast and Analysis
11. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS
11.3.1. Overview
11.3.2. Hospitals Market Forecast and Analysis
11.4. REGENERATIVE MEDICINE CENTERS
11.4.1. Overview
11.4.2. Regenerative Medicine Centers Market Forecast and Analysis
11.5. RESEARCH INSTITUTES
11.5.1. Overview
11.5.2. Research Institutes Market Forecast and Analysis
12. CELL THERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Cell Therapy Market Overview
12.1.2 North America Cell Therapy Market Forecasts and Analysis
12.1.3 North America Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.1.4 North America Cell Therapy Market Forecasts and Analysis - By Product
12.1.5 North America Cell Therapy Market Forecasts and Analysis - By Technology
12.1.6 North America Cell Therapy Market Forecasts and Analysis - By Application
12.1.7 North America Cell Therapy Market Forecasts and Analysis - By End User
12.1.8 North America Cell Therapy Market Forecasts and Analysis - By Countries
12.1.8.1 United States Cell Therapy Market
12.1.8.1.1 United States Cell Therapy Market by Therapy Type
12.1.8.1.2 United States Cell Therapy Market by Product
12.1.8.1.3 United States Cell Therapy Market by Technology
12.1.8.1.4 United States Cell Therapy Market by Application
12.1.8.1.5 United States Cell Therapy Market by End User
12.1.8.2 Canada Cell Therapy Market
12.1.8.2.1 Canada Cell Therapy Market by Therapy Type
12.1.8.2.2 Canada Cell Therapy Market by Product
12.1.8.2.3 Canada Cell Therapy Market by Technology
12.1.8.2.4 Canada Cell Therapy Market by Application
12.1.8.2.5 Canada Cell Therapy Market by End User
12.1.8.3 Mexico Cell Therapy Market
12.1.8.3.1 Mexico Cell Therapy Market by Therapy Type
12.1.8.3.2 Mexico Cell Therapy Market by Product
12.1.8.3.3 Mexico Cell Therapy Market by Technology
12.1.8.3.4 Mexico Cell Therapy Market by Application
12.1.8.3.5 Mexico Cell Therapy Market by End User
12.2. EUROPE
12.2.1 Europe Cell Therapy Market Overview
12.2.2 Europe Cell Therapy Market Forecasts and Analysis
12.2.3 Europe Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.2.4 Europe Cell Therapy Market Forecasts and Analysis - By Product
12.2.5 Europe Cell Therapy Market Forecasts and Analysis - By Technology
12.2.6 Europe Cell Therapy Market Forecasts and Analysis - By Application
12.2.7 Europe Cell Therapy Market Forecasts and Analysis - By End User
12.2.8 Europe Cell Therapy Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Cell Therapy Market
12.2.8.1.1 Germany Cell Therapy Market by Therapy Type
12.2.8.1.2 Germany Cell Therapy Market by Product
12.2.8.1.3 Germany Cell Therapy Market by Technology
12.2.8.1.4 Germany Cell Therapy Market by Application
12.2.8.1.5 Germany Cell Therapy Market by End User
12.2.8.2 France Cell Therapy Market
12.2.8.2.1 France Cell Therapy Market by Therapy Type
12.2.8.2.2 France Cell Therapy Market by Product
12.2.8.2.3 France Cell Therapy Market by Technology
12.2.8.2.4 France Cell Therapy Market by Application
12.2.8.2.5 France Cell Therapy Market by End User
12.2.8.3 Italy Cell Therapy Market
12.2.8.3.1 Italy Cell Therapy Market by Therapy Type
12.2.8.3.2 Italy Cell Therapy Market by Product
12.2.8.3.3 Italy Cell Therapy Market by Technology
12.2.8.3.4 Italy Cell Therapy Market by Application
12.2.8.3.5 Italy Cell Therapy Market by End User
12.2.8.4 Spain Cell Therapy Market
12.2.8.4.1 Spain Cell Therapy Market by Therapy Type
12.2.8.4.2 Spain Cell Therapy Market by Product
12.2.8.4.3 Spain Cell Therapy Market by Technology
12.2.8.4.4 Spain Cell Therapy Market by Application
12.2.8.4.5 Spain Cell Therapy Market by End User
12.2.8.5 United Kingdom Cell Therapy Market
12.2.8.5.1 United Kingdom Cell Therapy Market by Therapy Type
12.2.8.5.2 United Kingdom Cell Therapy Market by Product
12.2.8.5.3 United Kingdom Cell Therapy Market by Technology
12.2.8.5.4 United Kingdom Cell Therapy Market by Application
12.2.8.5.5 United Kingdom Cell Therapy Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Cell Therapy Market Overview
12.3.2 Asia-Pacific Cell Therapy Market Forecasts and Analysis
12.3.3 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.3.4 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Product
12.3.5 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Technology
12.3.6 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Application
12.3.7 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Cell Therapy Market
12.3.8.1.1 Australia Cell Therapy Market by Therapy Type
12.3.8.1.2 Australia Cell Therapy Market by Product
12.3.8.1.3 Australia Cell Therapy Market by Technology
12.3.8.1.4 Australia Cell Therapy Market by Application
12.3.8.1.5 Australia Cell Therapy Market by End User
12.3.8.2 China Cell Therapy Market
12.3.8.2.1 China Cell Therapy Market by Therapy Type
12.3.8.2.2 China Cell Therapy Market by Product
12.3.8.2.3 China Cell Therapy Market by Technology
12.3.8.2.4 China Cell Therapy Market by Application
12.3.8.2.5 China Cell Therapy Market by End User
12.3.8.3 India Cell Therapy Market
12.3.8.3.1 India Cell Therapy Market by Therapy Type
12.3.8.3.2 India Cell Therapy Market by Product
12.3.8.3.3 India Cell Therapy Market by Technology
12.3.8.3.4 India Cell Therapy Market by Application
12.3.8.3.5 India Cell Therapy Market by End User
12.3.8.4 Japan Cell Therapy Market
12.3.8.4.1 Japan Cell Therapy Market by Therapy Type
12.3.8.4.2 Japan Cell Therapy Market by Product
12.3.8.4.3 Japan Cell Therapy Market by Technology
12.3.8.4.4 Japan Cell Therapy Market by Application
12.3.8.4.5 Japan Cell Therapy Market by End User
12.3.8.5 South Korea Cell Therapy Market
12.3.8.5.1 South Korea Cell Therapy Market by Therapy Type
12.3.8.5.2 South Korea Cell Therapy Market by Product
12.3.8.5.3 South Korea Cell Therapy Market by Technology
12.3.8.5.4 South Korea Cell Therapy Market by Application
12.3.8.5.5 South Korea Cell Therapy Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Cell Therapy Market Overview
12.4.2 Middle East and Africa Cell Therapy Market Forecasts and Analysis
12.4.3 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.4.4 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Product
12.4.5 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Technology
12.4.6 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Application
12.4.7 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Cell Therapy Market
12.4.8.1.1 South Africa Cell Therapy Market by Therapy Type
12.4.8.1.2 South Africa Cell Therapy Market by Product
12.4.8.1.3 South Africa Cell Therapy Market by Technology
12.4.8.1.4 South Africa Cell Therapy Market by Application
12.4.8.1.5 South Africa Cell Therapy Market by End User
12.4.8.2 Saudi Arabia Cell Therapy Market
12.4.8.2.1 Saudi Arabia Cell Therapy Market by Therapy Type
12.4.8.2.2 Saudi Arabia Cell Therapy Market by Product
12.4.8.2.3 Saudi Arabia Cell Therapy Market by Technology
12.4.8.2.4 Saudi Arabia Cell Therapy Market by Application
12.4.8.2.5 Saudi Arabia Cell Therapy Market by End User
12.4.8.3 U.A.E Cell Therapy Market
12.4.8.3.1 U.A.E Cell Therapy Market by Therapy Type
12.4.8.3.2 U.A.E Cell Therapy Market by Product
12.4.8.3.3 U.A.E Cell Therapy Market by Technology
12.4.8.3.4 U.A.E Cell Therapy Market by Application
12.4.8.3.5 U.A.E Cell Therapy Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Cell Therapy Market Overview
12.5.2 South and Central America Cell Therapy Market Forecasts and Analysis
12.5.3 South and Central America Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.5.4 South and Central America Cell Therapy Market Forecasts and Analysis - By Product
12.5.5 South and Central America Cell Therapy Market Forecasts and Analysis - By Technology
12.5.6 South and Central America Cell Therapy Market Forecasts and Analysis - By Application
12.5.7 South and Central America Cell Therapy Market Forecasts and Analysis - By End User
12.5.8 South and Central America Cell Therapy Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Cell Therapy Market
12.5.8.1.1 Brazil Cell Therapy Market by Therapy Type
12.5.8.1.2 Brazil Cell Therapy Market by Product
12.5.8.1.3 Brazil Cell Therapy Market by Technology
12.5.8.1.4 Brazil Cell Therapy Market by Application
12.5.8.1.5 Brazil Cell Therapy Market by End User
12.5.8.2 Argentina Cell Therapy Market
12.5.8.2.1 Argentina Cell Therapy Market by Therapy Type
12.5.8.2.2 Argentina Cell Therapy Market by Product
12.5.8.2.3 Argentina Cell Therapy Market by Technology
12.5.8.2.4 Argentina Cell Therapy Market by Application
12.5.8.2.5 Argentina Cell Therapy Market by End User
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. CELL THERAPY MARKET, KEY COMPANY PROFILES
14.1. KOLON TISSUEGENE, INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. MEDIPOST
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. JCR PHARMACEUTICALS CO. LTD.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. STEMEDICA CELL TECHNOLOGIES, INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. OSIRIS THERAPEUTICS, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. NUVASIVE, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. FIBROCELL SCIENCE, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. VERICEL CORPORATION
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. CELLS FOR CELLS
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. CELGENE CORPORATION
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell Therapy Market - By Therapy Type
1.3.2 Cell Therapy Market - By Product
1.3.3 Cell Therapy Market - By Technology
1.3.4 Cell Therapy Market - By Application
1.3.5 Cell Therapy Market - By End User
1.3.6 Cell Therapy Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CELL THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL THERAPY - GLOBAL MARKET OVERVIEW
6.2. CELL THERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. AUTOLOGOUS
7.3.1. Overview
7.3.2. Autologous Market Forecast and Analysis
7.4. ALLOGENEIC
7.4.1. Overview
7.4.2. Allogeneic Market Forecast and Analysis
8. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. EQUIPMENT
8.3.1. Overview
8.3.2. Equipment Market Forecast and Analysis
8.4. CONSUMABLES
8.4.1. Overview
8.4.2. Consumables Market Forecast and Analysis
8.5. SOFTWARE AND SERVICES
8.5.1. Overview
8.5.2. Software and Services Market Forecast and Analysis
9. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. SOMATIC CELL TECHNOLOGY
9.3.1. Overview
9.3.2. Somatic Cell Technology Market Forecast and Analysis
9.4. CELL IMMORTALIZATION TECHNOLOGY
9.4.1. Overview
9.4.2. Cell Immortalization Technology Market Forecast and Analysis
9.5. VIRAL VECTOR TECHNOLOGY
9.5.1. Overview
9.5.2. Viral Vector Technology Market Forecast and Analysis
9.6. GENOME EDITING TECHNOLOGY
9.6.1. Overview
9.6.2. Genome Editing Technology Market Forecast and Analysis
9.7. CELL PLASTICITY TECHNOLOGY
9.7.1. Overview
9.7.2. Cell Plasticity Technology Market Forecast and Analysis
9.8. THREE-DIMENSIONAL TECHNOLOGY
9.8.1. Overview
9.8.2. Three-Dimensional Technology Market Forecast and Analysis
10. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. ONCOLOGY
10.3.1. Overview
10.3.2. Oncology Market Forecast and Analysis
10.4. CARDIOLOGY
10.4.1. Overview
10.4.2. Cardiology Market Forecast and Analysis
10.5. ORTHOPEDIC
10.5.1. Overview
10.5.2. Orthopedic Market Forecast and Analysis
10.6. WOUND MANAGEMENT
10.6.1. Overview
10.6.2. Wound Management Market Forecast and Analysis
10.7. OTHER APPLICATIONS
10.7.1. Overview
10.7.2. Other Applications Market Forecast and Analysis
11. CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS
11.3.1. Overview
11.3.2. Hospitals Market Forecast and Analysis
11.4. REGENERATIVE MEDICINE CENTERS
11.4.1. Overview
11.4.2. Regenerative Medicine Centers Market Forecast and Analysis
11.5. RESEARCH INSTITUTES
11.5.1. Overview
11.5.2. Research Institutes Market Forecast and Analysis
12. CELL THERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Cell Therapy Market Overview
12.1.2 North America Cell Therapy Market Forecasts and Analysis
12.1.3 North America Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.1.4 North America Cell Therapy Market Forecasts and Analysis - By Product
12.1.5 North America Cell Therapy Market Forecasts and Analysis - By Technology
12.1.6 North America Cell Therapy Market Forecasts and Analysis - By Application
12.1.7 North America Cell Therapy Market Forecasts and Analysis - By End User
12.1.8 North America Cell Therapy Market Forecasts and Analysis - By Countries
12.1.8.1 United States Cell Therapy Market
12.1.8.1.1 United States Cell Therapy Market by Therapy Type
12.1.8.1.2 United States Cell Therapy Market by Product
12.1.8.1.3 United States Cell Therapy Market by Technology
12.1.8.1.4 United States Cell Therapy Market by Application
12.1.8.1.5 United States Cell Therapy Market by End User
12.1.8.2 Canada Cell Therapy Market
12.1.8.2.1 Canada Cell Therapy Market by Therapy Type
12.1.8.2.2 Canada Cell Therapy Market by Product
12.1.8.2.3 Canada Cell Therapy Market by Technology
12.1.8.2.4 Canada Cell Therapy Market by Application
12.1.8.2.5 Canada Cell Therapy Market by End User
12.1.8.3 Mexico Cell Therapy Market
12.1.8.3.1 Mexico Cell Therapy Market by Therapy Type
12.1.8.3.2 Mexico Cell Therapy Market by Product
12.1.8.3.3 Mexico Cell Therapy Market by Technology
12.1.8.3.4 Mexico Cell Therapy Market by Application
12.1.8.3.5 Mexico Cell Therapy Market by End User
12.2. EUROPE
12.2.1 Europe Cell Therapy Market Overview
12.2.2 Europe Cell Therapy Market Forecasts and Analysis
12.2.3 Europe Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.2.4 Europe Cell Therapy Market Forecasts and Analysis - By Product
12.2.5 Europe Cell Therapy Market Forecasts and Analysis - By Technology
12.2.6 Europe Cell Therapy Market Forecasts and Analysis - By Application
12.2.7 Europe Cell Therapy Market Forecasts and Analysis - By End User
12.2.8 Europe Cell Therapy Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Cell Therapy Market
12.2.8.1.1 Germany Cell Therapy Market by Therapy Type
12.2.8.1.2 Germany Cell Therapy Market by Product
12.2.8.1.3 Germany Cell Therapy Market by Technology
12.2.8.1.4 Germany Cell Therapy Market by Application
12.2.8.1.5 Germany Cell Therapy Market by End User
12.2.8.2 France Cell Therapy Market
12.2.8.2.1 France Cell Therapy Market by Therapy Type
12.2.8.2.2 France Cell Therapy Market by Product
12.2.8.2.3 France Cell Therapy Market by Technology
12.2.8.2.4 France Cell Therapy Market by Application
12.2.8.2.5 France Cell Therapy Market by End User
12.2.8.3 Italy Cell Therapy Market
12.2.8.3.1 Italy Cell Therapy Market by Therapy Type
12.2.8.3.2 Italy Cell Therapy Market by Product
12.2.8.3.3 Italy Cell Therapy Market by Technology
12.2.8.3.4 Italy Cell Therapy Market by Application
12.2.8.3.5 Italy Cell Therapy Market by End User
12.2.8.4 Spain Cell Therapy Market
12.2.8.4.1 Spain Cell Therapy Market by Therapy Type
12.2.8.4.2 Spain Cell Therapy Market by Product
12.2.8.4.3 Spain Cell Therapy Market by Technology
12.2.8.4.4 Spain Cell Therapy Market by Application
12.2.8.4.5 Spain Cell Therapy Market by End User
12.2.8.5 United Kingdom Cell Therapy Market
12.2.8.5.1 United Kingdom Cell Therapy Market by Therapy Type
12.2.8.5.2 United Kingdom Cell Therapy Market by Product
12.2.8.5.3 United Kingdom Cell Therapy Market by Technology
12.2.8.5.4 United Kingdom Cell Therapy Market by Application
12.2.8.5.5 United Kingdom Cell Therapy Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Cell Therapy Market Overview
12.3.2 Asia-Pacific Cell Therapy Market Forecasts and Analysis
12.3.3 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.3.4 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Product
12.3.5 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Technology
12.3.6 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Application
12.3.7 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Cell Therapy Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Cell Therapy Market
12.3.8.1.1 Australia Cell Therapy Market by Therapy Type
12.3.8.1.2 Australia Cell Therapy Market by Product
12.3.8.1.3 Australia Cell Therapy Market by Technology
12.3.8.1.4 Australia Cell Therapy Market by Application
12.3.8.1.5 Australia Cell Therapy Market by End User
12.3.8.2 China Cell Therapy Market
12.3.8.2.1 China Cell Therapy Market by Therapy Type
12.3.8.2.2 China Cell Therapy Market by Product
12.3.8.2.3 China Cell Therapy Market by Technology
12.3.8.2.4 China Cell Therapy Market by Application
12.3.8.2.5 China Cell Therapy Market by End User
12.3.8.3 India Cell Therapy Market
12.3.8.3.1 India Cell Therapy Market by Therapy Type
12.3.8.3.2 India Cell Therapy Market by Product
12.3.8.3.3 India Cell Therapy Market by Technology
12.3.8.3.4 India Cell Therapy Market by Application
12.3.8.3.5 India Cell Therapy Market by End User
12.3.8.4 Japan Cell Therapy Market
12.3.8.4.1 Japan Cell Therapy Market by Therapy Type
12.3.8.4.2 Japan Cell Therapy Market by Product
12.3.8.4.3 Japan Cell Therapy Market by Technology
12.3.8.4.4 Japan Cell Therapy Market by Application
12.3.8.4.5 Japan Cell Therapy Market by End User
12.3.8.5 South Korea Cell Therapy Market
12.3.8.5.1 South Korea Cell Therapy Market by Therapy Type
12.3.8.5.2 South Korea Cell Therapy Market by Product
12.3.8.5.3 South Korea Cell Therapy Market by Technology
12.3.8.5.4 South Korea Cell Therapy Market by Application
12.3.8.5.5 South Korea Cell Therapy Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Cell Therapy Market Overview
12.4.2 Middle East and Africa Cell Therapy Market Forecasts and Analysis
12.4.3 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.4.4 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Product
12.4.5 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Technology
12.4.6 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Application
12.4.7 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Cell Therapy Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Cell Therapy Market
12.4.8.1.1 South Africa Cell Therapy Market by Therapy Type
12.4.8.1.2 South Africa Cell Therapy Market by Product
12.4.8.1.3 South Africa Cell Therapy Market by Technology
12.4.8.1.4 South Africa Cell Therapy Market by Application
12.4.8.1.5 South Africa Cell Therapy Market by End User
12.4.8.2 Saudi Arabia Cell Therapy Market
12.4.8.2.1 Saudi Arabia Cell Therapy Market by Therapy Type
12.4.8.2.2 Saudi Arabia Cell Therapy Market by Product
12.4.8.2.3 Saudi Arabia Cell Therapy Market by Technology
12.4.8.2.4 Saudi Arabia Cell Therapy Market by Application
12.4.8.2.5 Saudi Arabia Cell Therapy Market by End User
12.4.8.3 U.A.E Cell Therapy Market
12.4.8.3.1 U.A.E Cell Therapy Market by Therapy Type
12.4.8.3.2 U.A.E Cell Therapy Market by Product
12.4.8.3.3 U.A.E Cell Therapy Market by Technology
12.4.8.3.4 U.A.E Cell Therapy Market by Application
12.4.8.3.5 U.A.E Cell Therapy Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Cell Therapy Market Overview
12.5.2 South and Central America Cell Therapy Market Forecasts and Analysis
12.5.3 South and Central America Cell Therapy Market Forecasts and Analysis - By Therapy Type
12.5.4 South and Central America Cell Therapy Market Forecasts and Analysis - By Product
12.5.5 South and Central America Cell Therapy Market Forecasts and Analysis - By Technology
12.5.6 South and Central America Cell Therapy Market Forecasts and Analysis - By Application
12.5.7 South and Central America Cell Therapy Market Forecasts and Analysis - By End User
12.5.8 South and Central America Cell Therapy Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Cell Therapy Market
12.5.8.1.1 Brazil Cell Therapy Market by Therapy Type
12.5.8.1.2 Brazil Cell Therapy Market by Product
12.5.8.1.3 Brazil Cell Therapy Market by Technology
12.5.8.1.4 Brazil Cell Therapy Market by Application
12.5.8.1.5 Brazil Cell Therapy Market by End User
12.5.8.2 Argentina Cell Therapy Market
12.5.8.2.1 Argentina Cell Therapy Market by Therapy Type
12.5.8.2.2 Argentina Cell Therapy Market by Product
12.5.8.2.3 Argentina Cell Therapy Market by Technology
12.5.8.2.4 Argentina Cell Therapy Market by Application
12.5.8.2.5 Argentina Cell Therapy Market by End User
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. CELL THERAPY MARKET, KEY COMPANY PROFILES
14.1. KOLON TISSUEGENE, INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. MEDIPOST
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. JCR PHARMACEUTICALS CO. LTD.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. STEMEDICA CELL TECHNOLOGIES, INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. OSIRIS THERAPEUTICS, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. NUVASIVE, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. FIBROCELL SCIENCE, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. VERICEL CORPORATION
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. CELLS FOR CELLS
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. CELGENE CORPORATION
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Kolon TissueGene, Inc.
2. MEDIPOST
3. JCR Pharmaceuticals Co. Ltd.
4. Stemedica Cell Technologies, Inc.
5. Osiris Therapeutics, Inc.
6. NuVasive, Inc.
7. Fibrocell Science, Inc.
8. Vericel Corporation
9. Cells for Cells
10. Celgene Corporation
1. Kolon TissueGene, Inc.
2. MEDIPOST
3. JCR Pharmaceuticals Co. Ltd.
4. Stemedica Cell Technologies, Inc.
5. Osiris Therapeutics, Inc.
6. NuVasive, Inc.
7. Fibrocell Science, Inc.
8. Vericel Corporation
9. Cells for Cells
10. Celgene Corporation